Article info
PDFNeurological rarities
Congenital myasthenic syndrome from a MUSK gene mutation
- Correspondence to Dr Antonia McLean, Neurology, Cairns Hospital, Cairns North, Queensland, 4870, Australia; antonia.mclean2{at}health.qld.gov.au
Citation
Congenital myasthenic syndrome from a MUSK gene mutation
Publication history
- Accepted October 31, 2023
- First published November 20, 2023.
Online issue publication
May 29, 2024
Article Versions
- Previous version (20 November 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Neuromuscular junction disorders: mimics and chameleons
- Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
- Myasthenia and related disorders of the neuromuscular junction
- A ‘limb-girdle muscular dystrophy’ responsive to asthma therapy
- Congenital familial myasthenic syndromes: disease and course in an affected dizygotic twin pair
- Clinical features of the myasthenic syndrome arising from mutations in GMPPB
- Congenital myasthenic syndromes: an update
- Congenital myasthenic syndromes
- Homozygous C-terminal loss-of-function NaV1.4 variant in a patient with congenital myasthenic syndrome
- Patients with a phenotype consistent with facioscapulohumeral muscular dystrophy display genetic and epigenetic heterogeneity